Sodium Methanesulfinate CAS 20277-69-4 Munditia >96.0%

Description:

Chemical Name: Sodium Methanesulfinate

CAS: 20277-69-4

Aspectus: Alba vel Off-White Crystal Pulvis

Puritas: >96.0%

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com 


Product Detail

Related Products

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica sodium Methanesulfinates (CAS: 20277-69-4) cum qualitate alta.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Sodium Methanesulfinate,Please contact: alvin@ruifuchem.com

Lapatinib Mediis:

Chemical Properties:

Nomen chemicum Sodium Methanesulfinate
Synonyma Methanesulfinic Acidum Sodium Salis
CAS Number 20277-69-4
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae CH5NaO2S
M. Pondus 104.1
Liquescens punctum 222.0~ 226.0' (decl.)
Aqua Solubility Solutum in aqua
Sensitiva Air Sensitiva & Hygroscopic
COA & MSDS Praesto
Origin Shanghai, China
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba vel Off-White Crystalli pulveris
Puritas >96.0%
Damnum in siccitate <1.00%
Infrared Imaginis Conformat ut Structure
Proton NMR Spectrum Conformat ut Structure
Test Standard Enterprise Standard
Consuetudinem Pharmaceutical Intermedia;Synthesis organica

Sarcina & Repono:

3

commoda:

10

FAQ:

www.ruifuchem.com

20277-69-4 - Periculum et Salus;

Periculum symbola Xn - Noxia
Periculum Codes R22 - noxia absorptus
R20/21/22 - Inspiratio noxia, in contactu cum cute et absorpta.
Salus Descriptio S36/37 - indumentis tutelae idoneis gere et caestus.
S24/25 - contactus cum cute et oculis fuge.
Consociatione Nationum IDs 2811
WGK Germania 3
Stipare Group III

20277-69-4 - Applicatio:

Shanghai Ruifu Chemical Co., Ltd. copia mercatorum Sodium Methanesulfinate (CAS: 20277-69-4).Medium pharmaceuticum magni momenti est, quod in productione API adhiberi potest (CAS 231277-92-2) et (CAS 388082-78-8) API aliisve mediis.(CAS 388082-78-8), novum membrum ordinis inhibitorum RTK inhibitorum 4-anilinoquinazolini (RTKIs), sicut curationem oralem pro cancro pectori immissa est.Dualem affinitatem habet cum EGFR et HER2 tyrosinis kinasibus.Indicatur in compositione cum Capecitabine curandis aegris cum carcinomate provectio vel metastatico pectoris, cuius tumores HER2 superexprimunt et qui priora therapiam in anthracyclinam, taxaneum et trastuzumab receperunt.

Epistulam tuam hic scribe et mitte nobis